ESC-RCC carries mutations in TSC1 or TSC2, with recurrent mutually exclusive somatic bi-allelic loss of TSC1/2, being recognized as a molecular marker for ESC-RCC [25,29,39]. This evidence concerns the gene TSC2 and renal cell carcinoma.